Venetoclax in Combination With ASTX727
Venetoclax in Combination With ASTX727, an All-Oral Therapy for Chronic Myelomonocytic Leukemia and Other MDS/MPN With Excess Blasts (VICTORY-MDS/MPN): A Randomized, Phase 2 Trial
Near Add Your Location
Sorting 24 by
Center of Excellence
University of Kansas Cancer Center (Westwood)
Westwood, KS
- Accepting patients
- Accepting patients
Center of Excellence
Robert H. Lurie Comprehensive Cancer Center
Northwestern University Feinberg School of Medicine
Chicago, IL
- Accepting patients
Virginia Commonwealth University Medical Center
Richmond, VA
- Accepting patients
University of Oklahoma Health Sciences Center
Oklahoma City, OK
- Accepting patients
UCI Health - Costa Mesa
Costa Mesa, CA
- Accepting patients
- Accepting patients
Center of Excellence
- Accepting patients
UCI Health (Laguna Hills)
Laguna Hills, CA
- Accepting patients
Montefiore Medical Center (Moses Campus)
The Bronx, NY
- Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.